Artiva Biotherapeutics Statistics Share Statistics Artiva Biotherapeutics has 24.36M
shares outstanding. The number of shares has increased by 0.31%
in one year.
Shares Outstanding 24.36M Shares Change (YoY) 0.31% Shares Change (QoQ) 0% Owned by Institutions (%) 85.94% Shares Floating 5.38M Failed to Deliver (FTD) Shares 4,683 FTD / Avg. Volume 2.28%
Short Selling Information The latest short interest is 304.48K, so 1.25% of the outstanding
shares have been sold short.
Short Interest 304.48K Short % of Shares Out 1.25% Short % of Float 3.13% Short Ratio (days to cover) 4.51
Valuation Ratios The PE ratio is -1.94 and the forward
PE ratio is -0.98.
Artiva Biotherapeutics's PEG ratio is
-0.01.
PE Ratio -1.94 Forward PE -0.98 PS Ratio 452.15 Forward PS 223.6 PB Ratio 0.61 P/FCF Ratio -2.04 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Artiva Biotherapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 15.39,
with a Debt / Equity ratio of 0.08.
Current Ratio 15.39 Quick Ratio 15.39 Debt / Equity 0.08 Debt / EBITDA -0.22 Debt / FCF -0.26 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $2.61K Profits Per Employee $-609.3K Employee Count 96 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -69.97% in the
last 52 weeks. The beta is 5.29, so Artiva Biotherapeutics's
price volatility has been higher than the market average.
Beta 5.29 52-Week Price Change -69.97% 50-Day Moving Average 2.6 200-Day Moving Average 4.64 Relative Strength Index (RSI) 66.87 Average Volume (20 Days) 205,543
Income Statement In the last 12 months, Artiva Biotherapeutics had revenue of 251K
and earned -58.49M
in profits. Earnings per share was -5.2.
Revenue 251K Gross Profit 251K Operating Income -67.28M Net Income -58.49M EBITDA -64.85M EBIT -67.28M Earnings Per Share (EPS) -5.2
Full Income Statement Balance Sheet The company has 40.23M in cash and 14.35M in
debt, giving a net cash position of 25.88M.
Cash & Cash Equivalents 40.23M Total Debt 14.35M Net Cash 25.88M Retained Earnings -246.68M Total Assets 169.39M Working Capital 138.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -55.03M
and capital expenditures -642K, giving a free cash flow of -55.67M.
Operating Cash Flow -55.03M Capital Expenditures -642K Free Cash Flow -55.67M FCF Per Share -4.94
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -26805.58% and -23303.98%.
Gross Margin 100% Operating Margin -26805.58% Pretax Margin -23303.98% Profit Margin -23303.98% EBITDA Margin -25837.05% EBIT Margin -26805.58% FCF Margin -22180.88%
